序贯疗法根除幽门螺旋杆菌的疗效观察
2017-02-28刘静
刘静
摘要:目的 比较10 d序贯疗法与标准三联疗法根除HP(幽门螺旋杆菌)疗效。方法 选100例快速尿素酶实验阳性的病例,随机分为两组,治疗组、对照组各50例,治疗组前5 d用泮托拉唑+阿莫西林,后5 d用泮托拉唑+四环素+呋喃唑酮,对照组用泮托拉唑+阿莫西林+克拉霉素 14 d。结果 Hp根除率治疗组93.0%,对照组81.9%,两组间差异有统计学意义(P<0.05)。结论 以泮托拉唑、呋喃唑酮等组成的10 d序贯疗法治疗Hp感染具有较高的根除率,安全性好。
关键词:幽门螺杆菌;序贯疗法;三联疗法
Abstract:Objective To compare the curative effects between 10 days sequential therapy and tradition therapy for eradieation of helicobacter pylori. Methods Choose 100 patients of Rapid urease test Positive ,and divide them into two teams at random(50 patients into the treatment group, and another 50 into the group for contrast). In the first five days, patients in the treatment group are to be prescribed with pantoprazole and amoxillin, after that, another five days with pantoprazole, tetracycline, and furazolidone while the group for contrast with pantoprazole, amoxillin ,clarithromycin, and for 14 days. Results The eradication rate of the treatment group was 93.0% and that of the control group was 81.9%. The statistical significance exists in the differences between the two teams (P<0.05). Conclusion 10 days sequential therapy constituted of the medicine, such as pantoprazole、furazolidone is highly effective and safe to eradicate the Hp during the treating process.
Key words:Helicobacter pylori ;Sequential therapy;Triple therapy
我国是HP感染较高的国家,约40%~60%,HP在慢性胃炎、消化性溃疡等上消化道疾病中的作用已被确定,第四次全国幽门螺杆菌感染处理共识报告指出慢性胃炎伴糜烂、萎缩、消化性溃疡、早期胃癌术后、胃粘膜相关淋巴组织(MALT)淋巴瘤必须治疗[1],Hp根除以后上述疾病的治愈率明显提高,复发率明显减低[2],但是随着抗生素广泛应用及不规范应用,耐药问题十分严重,标准的三联方案的根除率明显降低,迫使我们寻找新的治疗方法,根据文献资料显示,序贯疗法较标准三联疗法具有更好地疗效[3],我在工作中采用10 d序贯疗法根除Hp取得了较好的疗效,现报告如下。
1 资料与方法
1.1一般资料 选取2013年8月~2015年11月本科经胃镜检查诊断为消化性溃疡、慢性胃炎伴糜烂及经快速尿素酶实验Hp检测阳性的病例100例,治疗前1个月内均未使用过阿莫西林、甲硝唑、克拉霉素、四环素、呋喃唑酮、铋剂及质子泵抑制剂排除妊娠或合并严重心、肝、肾疾患、药物过敏史,且均为初治患者。将100例患者随机分为两组,治疗组50例,男27例,女23例,年齡22~69岁;消化性溃疡33例,慢性胃炎17例。……
